MedPath

A retrospective study evaluating effectiveness of primary brain radiotherapy with TKI for driver gene mutation-positive advanced non-small cell lung cancer with asymptomatic brain metastases.

Not Applicable
Conditions
non-small cell lung cancer
Registration Number
JPRN-UMIN000046961
Lead Sponsor
Shimane University Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
300
Inclusion Criteria

Not provided

Exclusion Criteria

1. The physician has determined that it is inappropriate.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
intracranial progression free survival
Secondary Outcome Measures
NameTimeMethod
overall survival, best overall response of intracranial lesions, time to onset of central nervous system symptoms, TKI treatment period, progression free survival, best overall response, safety of head radiation therapy
© Copyright 2025. All Rights Reserved by MedPath